Literature DB >> 1846332

Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma.

S J Szefler1, R Ando, L C Cicutto, W Surs, M R Hill, R J Martin.   

Abstract

Plasma histamine, cortisol, epinephrine, cyclic adenosine monophosphate (cAMP), and leukocyte beta-adrenergic receptors were measured in asthmatic patients with (n = 7) and without (n = 10) nocturnal asthma at 4 PM and 4 AM and compared with those of normal subjects (n = 10). A twofold higher plasma histamine concentration was observed at 4 AM compared with 4 PM in all groups, with no change in plasma cortisol, epinephrine, and cAMP concentrations. At 4 AM compared with 4 PM, only patients with nocturnal asthma had a significant 33% decrease (p less than 0.05) in mononuclear and polymorphonuclear leukocyte beta-adrenergic receptor density, with no difference in binding affinity in all three groups. Polymorphonuclear leukocytes from patients with nocturnal asthma had significantly impaired response to isoproterenol at 4 AM (17% +/- 7.3% SEM increase in cAMP; p less than 0.05) compared with those of patients without nocturnal asthma (69.4% +/- 13.7%) and normal (80.2% +/- 21.3%) subjects. A significant change in beta-adrenergic receptor density and function occurs at night in patients with nocturnal asthma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846332     DOI: 10.1038/clpt.1991.11

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

Review 1.  Childhood asthma--advances in pathogenesis.

Authors:  N Somu; N C Gowrishankar; L Subramaniam; D Vijayasekaran; B M Muhajir; A Balachandran
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

2.  Beta 2 adrenoceptor polymorphisms: are they clinically important?

Authors:  I P Hall
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

3.  Sleep and Obstructive Lung Diseases.

Authors:  Michael E Ezzie; Jonathan P Parsons; John G Mastronarde
Journal:  Sleep Med Clin       Date:  2008-12

Review 4.  Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

Authors:  T D Holimon; C C Chafin; T H Self
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  The impact of family asthma management on biology: a longitudinal investigation of youth with asthma.

Authors:  Hope A Walker; Edith Chen
Journal:  J Behav Med       Date:  2010-04-07

6.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

Authors:  J Turki; J Pak; S A Green; R J Martin; S B Liggett
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Role of inflammation in nocturnal asthma.

Authors:  T W Mackay; W A Wallace; S E Howie; P H Brown; A P Greening; M K Church; N J Douglas
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

Review 8.  Beta 2 adrenergic receptors in asthma: a current perspective.

Authors:  T R Bai
Journal:  Lung       Date:  1992       Impact factor: 2.584

Review 9.  Severe upper airway obstruction during sleep.

Authors:  H William Bonekat; Kimberly A Hardin
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

10.  [Relevance of sleep for patients with lung diseases].

Authors:  H F Becker
Journal:  Internist (Berl)       Date:  2004-09       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.